Diffusion Histology Imaging Detects and Classifies Glioblastoma Pathology Missed by Conventional Magnetic Resonance Imaging
Zezhong Ye,R. Price,Xiran Liu,Joshua Lin,Qingsong Yang,P. Sun,Anthony T. Wu,Liang Wang,Rowland H. Han,Chunyu Song,Ruimeng Yang,Sam E. Gary,Diane D. Mao,M. Wallendorf,J. Campian,Jr-Shin Li,S. Dahiya,A. Kim,Sheng-Kwei Song
DOI: https://doi.org/10.1101/843367
2019-01-01
bioRxiv
Abstract:Background Glioblastoma (GBM) is one of the deadliest cancers with no cure. While conventional MRI has been widely adopted for examining GBM clinically, accurate neuroimaging assessment of tumor histopathology for improved diagnosis, surgical planning, and treatment evaluation, remains an unmet need in the clinical management of GBMs. Methods We employ a novel Diffusion Histology Imaging (DHI) approach, combining diffusion basis spectrum imaging (DBSI) and machine learning, to detect, differentiate, and quantify areas of high cellularity, tumor necrosis, and tumor infiltration in GBM. Results Gd-enhanced T1W or hyper-intense FLAIR failed to reflect the morphological complexity underlying tumor in GBM patients. Contrary to the conventional wisdom that apparent diffusion coefficient (ADC) negatively correlates with increased tumor cellularity, we demonstrate disagreement between ADC and histologically confirmed tumor cellularity in glioblastoma specimens, whereas DBSI-derived restricted isotropic diffusion fraction positively correlated with tumor cellularity in the same specimens. By incorporating DBSI metrics as classifiers for a supervised machine learning algorithm, we accurately predicted high tumor cellularity, tumor necrosis, and tumor infiltration with 87.5%, 89.0% and 93.4% accuracy, respectively. Conclusion Our results suggest that DHI might serve as a favorable alternative to current neuroimaging techniques for guiding biopsy or surgery as well as monitoring therapeutic response in the treatment of glioblastoma. Key Points Clinical MRI lacks specificity and sensitivity in detecting morphological features in GBM. DBSI-derived morphological metrics reflect tumor cellularity, necrosis, and white matter tracts. DHI predicts and classifies key histopathological features of GBM. Importance of the Study Current clinical diagnosis, surgical resection planning, and assessment of treatment response for GBM patients relies heavily on gadolinium enhanced T1-weighted MRI, despite the enhancement is non-specific to tumor growth merely reflecting a disrupted blood-brain barrier. The complex tumor microenvironment and spatial heterogeneity make GBM very difficult to characterize using current clinical imaging modalities. In this study, we developed a novel imaging technique to characterize key histological features of GBM to accurately predict high tumor cellularity, tumor necrosis, and tumor infiltration. Current proof-of-concept approach if validated in a larger cohort of GBM patients could provide a solution resolve issues such as pseudoprogression and radiation necrosis currently plague neuroimaging modalities to assess GBM in living patients.